Accessibility statement

Who is involved in this study?

EMERALD is a two-year mixed methods study funded by the National Institute for Health Research (ref: 15/70/26). It is led by the Department of Health Sciences, University of York, and draws on expertise from the universities of Leeds and Southampton, Bradford District Care NHS Foundation Trust, and our Patient and Public Involvement panel DIAMONDS VOICE. The study is led by Dr Najma Siddiqi and forms part of the DIAMONDS research programme on severe mental illness and diabetes which sits under the Mental and Physical Health Multimorbidity research theme in the Mental Health and Addiction Research Group.

NHS studies are independently reviewed to ensure that research is conducted in accordance with robust ethical principles. EMERALD has been approved by Greater Manchester West Research Ethics Committee (IRAS no. 235328) and has been registered on ClinicalTrials.gov (ref. NCT03534921).

 Internal staff

Najma Siddiqi

Jo Taylor

Lu Han

Sue Bellass

Tim Doran

S‌imon Gilbody

 Rowena Jacobs

 Stephanie Prady

 Catherine Hewitt

 Kate Bosanquet

‌

 Nicky Traynor

‌

  

External collaborators

  • Richard Holt
  • John Radford
  • David Shiers
  • Sarah Alderson

Funded by National Institute for Health Research (Health Services and Delivery Research Programme).

This project is overseen by our independent Study Steering Committee (PDF , 380kb).

Start date: 1 September 2017
End date: 1 September 2019

NIHR disclaimer
This project was funded by the NIHR Health Services and Delivery Research Programme (ref 15/70/26).

The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.